EyewireTV

04.17.2024

Watch Episode

Stocks

Sort by:

Change A-Z

AbbVie $165.86 0.73%

Adverum Biotechnologies $11.04 -0.99%

Alcon $79.40 1.19%

Aldeyra Therapeutics $3.91 -1.88%

Alimera Sciences $3.44 -3.10%

Apellis Pharmaceuticals $47.00 -1.07%

Astellas Pharma $9.47 0.11%

Bausch + Lomb $14.47 1.05%

Bausch Health Companies $8.68 0.93%

Bayer $7.04 -0.21%

Biogen $191.16 0.34%

Can-Fite Biopharma $1.99 1.02%

Clearside Biomedical $1.42 7.58%

Cooper Companies $90.39 -0.02%

Eyenovia $0.55 2.69%

EyePoint Pharmaceuticals $17.08 -2.43%

Glaukos $97.62 2.62%

Harrow Health $10.29 -5.16%

Hill-Rom $155.96 0.03%

Horizon Therapeutics $116.30 0.00%

InMed Pharmaceuticals $0.30 0.33%

Iridex Corporation $3.02 -5.03%

Johnson & Johnson $146.68 0.64%

Kala Pharmaceuticals $6.81 0.00%

Kiora Pharmaceuticals $0.51 0.75%

Lensar $3.14 2.61%

Lineage Cell Therapeutics $1.16 -3.33%

MeiraGTx Holdings $5.04 0.60%

Merck & Company $125.13 -0.08%

National Vision Holdings $18.52 -1.10%

NovaBay Pharmaceuticals $0.08 1.33%

Novartis AG Common Stock $93.69 1.21%

Ocugen $1.29 -2.27%

Ocular Therapeutix $5.08 -13.40%

Oculis $11.78 -1.01%

Ocuphire Pharma $1.69 1.20%

Omeros Corp. $3.20 -0.47%

Osmotica $1.11 -1.77%

Outlook Therapeutics $8.38 1.03%

Palatin Technologies $1.89 -0.53%

Regeneron $897.14 0.35%

Regenxbio $15.95 -0.99%

Roche $30.05 -0.10%

Sight Sciences $5.27 0.57%

STAAR Surgical Company $46.92 0.31%

Takeda Pharmaceutical Company $13.24 0.61%

Tarsus Pharmaceuticals $32.83 -0.08%

Viatris $11.23 0.99%

View More Stocks

Cataract

A Need for Scientific Rigor

Manus C. Kraff, MD, a founding member and past president (1983–1985) of the ASCRS, reflects on the organization’s early days.

Gillian McDermott, MA, Editor-in-Chief, Clinical Content, Anterior Segment, BMC Vision

Cataract and Refractive Surgery Today

CRST: What was the impetus for creating the ASCRS? Manus C. Kraff, MD: ASCRS was created because ophthalmology at that time was starting to talk about IOLs, and the people who were doing IOLs could not get any space in journals or in meetings. It was kind of a taboo subject, especially with academia. The idea was to form a society that would put emphasis on these subjects that were not being permitted in other journals. CRST: What were the founding members’ goals for the organization? Dr. Kraff: We were looking to found an organization that would sponsor the formation of the science of lens implantation. At that time, there was not much control over the publication of papers as far as their scientific merit. This became relevant with radial keratotomy as well.

Dense Cataract in Pseudoexfoliation Syndrome

Marisa Schoen, MD

Eyetube

Rare Case of Retrolenticular Pseudohypopyon

Sarvesswaran Prakash, MD; Aditi Ghosh, MD; and Shivkumar Chandrashekaran, MD

Eyetube

Understanding Posterior Capsule Behavior

Jaime Zacharias, MD; Nicolas Berthet, MD; and Diego Orellana, MD

Eyetube

The Future of Hyperopic LASIK: Debates and Advances

William F. Wiley, MD, and Wesam Silk, MD

Eyetube

Management of Advanced Glaucoma

Nathan M. Radcliffe, MD; Blake Williamson, MD, MPH; and Gary Wörtz, MD

Eyetube

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.12.2024

Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRS

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

04.08.2024

Oculis Announces Positive Results from Phase 3 Trial of Once Daily Treatment for Inflammation and Pain Following Cataract Surgery

Eyewire News

Refractive

A Need for Scientific Rigor

Manus C. Kraff, MD, a founding member and past president (1983–1985) of the ASCRS, reflects on the organization’s early days.

Gillian McDermott, MA, Editor-in-Chief, Clinical Content, Anterior Segment, BMC Vision

Cataract and Refractive Surgery Today

The Future of Hyperopic LASIK: Debates and Advances

William F. Wiley, MD, and Wesam Silk, MD

Eyetube

Essential Preoperative Considerations

Clinical examination findings and diagnostic imaging are critical to success.

Tanya Trinh, MBBS, FRANZCO, FWCRS, and Nicole Fram, MD

Cataract and Refractive Surgery Today

Navigating Vitreous Loss in Cataract Surgery

An experienced retina surgeon shares his tips.

Steve Charles, MD, FACS, FICS

Cataract and Refractive Surgery Today

Management of Advanced Glaucoma

Nathan M. Radcliffe, MD; Blake Williamson, MD, MPH; and Gary Wörtz, MD

Eyetube

The Consumer Journey in Vision Correction

Insights from the Refractive Surgery Council.

Liana Miller and Lisa Spicer

Cataract and Refractive Surgery Today

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.11.2024

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgery

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Eyewire News

Stay Updated

Retina

Adopting Remote Monitoring and AI: Lessons From Cardiology

Learning from colleagues in other medical specialties can guide ophthalmology’s smooth transition.

Judy E. Kim, MD, FARVO, FASRS, and Jagmeet P. Singh, MD, ScM, PhD, FHRS, FACC

Retina Today

AT A GLANCE The use of remote monitoring and AI is inevitable in the field of retina. However, concerns related to workflow, liability, and reimbursement hinder its adoption in day-to-day practice. Cardiology has found remote monitoring and AI to be fundamental to modern practice, benefitting both patients and providers. By learning about cardiology’s experience with adopting remote monitoring and AI in clinical practice, ophthalmologists can anticipate (and adjust for) the new era in medicine. The more ophthalmology embraces remote monitoring, the better it can meet the needs of patients and reduce treatment burden. As regulatory bodies move closer to approving home-based imaging platforms, such as home OCT and AI-based software, ophthalmologists must prepare for more data-driven care. To learn more about what this transition entails, ophthalmology can turn to other specialties with experience in widespread adoption of AI and remote monitoring. Although we practice in separate domains of medicine—retina (Dr. Kim) and cardiology (Dr. Singh)—we share a passion for improving patient care through technology.

Multimodal Imaging in Uveitis

Recent imaging advances have improved our ability to diagnose and monitor this challenging condition.

Eric Jung, MD, and Sumit Sharma, MD

Retina Today

A Reference Guide for OCT Angiography

An illustrative overview of OCTA findings to help you implement this tool in common clinical scenarios.

Ivy Zhu, MD; Nicole L. Decker, BS; and Amani A. Fawzi, MD

Retina Today

Tailoring IVT Dosing With Vitreous Volume

We have heard the adage, “As much as necessary, as little as possible,” with regard to medication. Can we apply it to intravitreal therapy?

Andreas F. Borkenstein, MD

Retina Today

New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT

Sruthi Arepalli, MD, Vaidehi Dedania, MD, and Rebecca Soares, MD, MPH

Eyetube

Practice Makes Progress

Marion Munk, MD, and Justis P. Ehlers, MD

Retina Today

04.18.2024

Ocular Therapeutix’ Axpaxli in Diabetic Retinopathy Evaluated in Phase 1 HELIOS Clinical Trial

Eyewire News

04.16.2024

Regeneron Backs $500 Million Venture Capital Fund for Biotechnology Innovation

Eyewire News

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

Eyewire News

04.15.2024

In Japanese Study, Vabysmo Achieves Primary Endpoint in Phase 3 Study for Angioid Streaks

Eyewire News

Glaucoma

Establishing a Glaucoma Practice Fresh Out of Fellowship

Insights and strategies for young ophthalmologists in building a successful, specialized practice.

Emily M. Schehlein, MD

Glaucoma Today

All comprehensive and fellowship-trained ophthalmologists know that, upon graduating from our respective institutions, we have it all figured out. Ready to tackle any disease dilemma, we are armed with the latest peer-reviewed journal articles to back up our practices. Not just clinically and surgically adept, we also possess the business savvy of a CEO, the marketing genius of a top strategist, and the command of a thriving practice. Our patients view us as trusted, experienced, rock star surgeons. Red tape? We’ve never heard of it. Even insurance companies line up to send us letters of gratitude for joining their networks. When we wake from this glorious dream, we recognize that graduation is not the finish line but the starting point. I felt exceptionally well prepared when I completed my fellowship 18 months ago. I opted for a small, physician-owned private practice, one without a glaucoma specialist but with a team of fantastic physician colleagues and an outstanding support staff.

Seen & Heard

Glaucoma Today

Triple Threat: Combination OMNI and Hyrdus

Roman Krivochenitser, MD

Eyetube

iTrack Advance With iStent Infinite for Mild POAG

I. Paul Singh, MD

Eyetube

Genetics: Now or Later?

Why it’s time to know the basics.

Inas F. Aboobakar, MD

Glaucoma Today

The Glaucoma Tension

Arsham Sheybani, MD

Glaucoma Today

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.11.2024

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating Aqueous Outflow Restorative Procedure with OMNI

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Pupil Pod

A case-based podcast hosted by Sila Bal, MD, MPH, featuring all stages of the journey through ophthalmology, from first-year residents to the leading experts.

View Feed

Optometry

The Importance of Increasing OD-to-OD Referrals

And some tips on how to do so.

Jason Besecker, OD, MS

Modern Optometry

With subspecialization and collaboration, optometrists can provide the highest quality care and improve outcomes for our patients. In this article, I will focus on the need for both in our profession to address the increasing complexity of eye diseases, as well as the rapid rate of new diagnostic and therapeutic tools at our disposal. This increased complexity in diseases, diagnostics, and therapeutics makes it impractical—quite frankly, impossible—for a single practitioner to master all areas of optometry, requiring the need for dedicated experts on a condition or subset of conditions. ADOPT THE RIGHT MINDSET When optometrists make a decision, whether it be related to business or clinical care, our patients’ best interests should always be top of mind. According to the American Medical Association (AMA) Code of Ethics, “the relationship between a patient and a physician is based on trust, which gives rise to a physicians’ ethical responsibility to place patients’ welfare above the physician’s own self-interest or obligation to others, to use sound medical judgement on the patients’ behalf, and to advocate for their patients’ welfare.”1 I have seen colleagues fail to make necessary referrals, even when they know that other optometrists in their area provide specialty services that could improve a patient’s outcome. When asked for her thoughts about OD-to-OD referrals, Pam Theriot, OD, FAAO, says staying patient-centric has taught her to refer to her colleagues who specialize in other optometric specialties. “I love to refer my patients to another provider when I know they will have a better outcome,” she says. This is an excellent mindset that other optometrists can learn from—the importance of remaining patient-centric to ensure better outcomes—even if it means referring to another optometrist. Specialists offer more advanced insights on certain conditions, making them better equipped to establish solutions to more complex challenges. US News published a panel discussion on the advantages of the specialized approach in health care.2 One of the panelists, Harlan Levine, MD, suggested that many health care practitioners are concerned that referring patients to a specialist may result in them losing those patients, or what’s sometimes referred to as leakage.

Realize the Power of Comanagement

Build community with your local providers to ensure your patients receive the best possible care.

Jeff Banas, OD

Modern Optometry

Vision Correction Guidelines for Patients Approaching Presbyopia

Boost your multifocal contact lens fitting rates with effective patient engagement.

Osama Said, OD

Modern Optometry

In Consideration of House Calls and OD-to-OD Referrals

Eyetube

Don’t “Lump” All Lid Lesions Together

Be thorough in creating your differential diagnosis.

Jacob Lang, OD, FAAO

Modern Optometry

The Parasympathetic Nervous System and DED

The connection between the two suggests dry eye is more than just a disease of the eye.

Hardeep K. Kataria, OD, FAAO, and Mila Ioussifova, OD, FAAO, CNS

Modern Optometry

04.10.2024

Orbis Partners and Heidelberg Engineering Partner to Train Eye Care Professionals Around the World

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

04.05.2024

Wearing Glasses Boosts Income by a Third in Low-Income Communities, Finds Landmark New Study

Eyewire News

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Eyewire News

Business

Shielding Your Wealth From Potential Liability

The basics of a solid asset protection plan.

David B. Mandell, JD, MBA

Modern Optometry

Many optometrists are right to be concerned about potential liability. Life and work as a physician, practice owner, and parent bring with it many types of liability risks, including malpractice, employee claims, HIPAA violations, contract disputes, slip-and-falls, and car accidents. To shield wealth from these potential claims, eye care practitioners have the option to implement asset protection planning. A Sliding Scale As an initial step, an asset protection professional will approach a client with unprotected assets much in the way that a physician approaches a patient. Like physicians, asset protection professionals will first try to get a client to avoid bad habits. For a medical patient, bad habits might mean smoking, drinking too much, or a poor diet. From an asset protection standpoint, bad habits might include owning property in a physician’s own name, owning it jointly with a spouse, or operating any medical practice with business assets exposed. Beyond bad habits, asset protection specialists will try to structure assets so they have the best protection that is reasonably possible under the circumstances, which can include how much the client wants to spend, the value of the asset, and the client’s marital status, state of residence, and interest in estate planning. Each asset protection tool has certain efficacy and costs/benefits. The most common misconception that physicians have regarding asset protection is thinking that an asset is either “protected” or “not protected.” In reality, each asset is shielded from liability to a certain degree.

Tips for Retaining Staff and Keeping Them Happy

A solid team is at the core of any successful practice. Here’s how you can do your part as a leader to ensure employee satisfaction.

Michael J. Cymbor, OD, FAAO; Mila Ioussifova, OD, FAAO, CNS; and Caitlin Morrison, OD, FAAO, FSLS

Modern Optometry

Why You Should Hire an Associate OD

Welcoming another eye care practitioner to your practice can accelerate practice growth and expand your range of services offered.

Christopher Lopez, OD

Modern Optometry

Five Retina Coding Updates for 2024

Enter the new year with a better understanding of what to expect in your billing department.

Joy Woodke, COE, OCS, OCSR

Retina Today

Comparing AI-Generated Answers to Patients’ Eye Care Questions With Ophthalmologists’ Responses

Robert T. Chang, MD; and Neda Shamie, MD

Eyetube

The Good Life

Selina R. McGee, OD, FAAO; Justin Schweitzer, OD, FAAO; and Walter O. Whitley, OD, MBA, FAAO

Modern Optometry

04.16.2024

Regeneron Backs $500 Million Venture Capital Fund for Biotechnology Innovation

Eyewire News

04.16.2024

EyeSouth Partners Affiliates With Community Eye Care Specialists in New York

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.12.2024

False Claims Act Complaint Filed Against Regeneron for Fraudulent Drug Pricing Reporting

Eyewire News

EyewireTV

04.17.2024

04.17.2024

Executive Updates

Bausch + Lomb

Alcon

AbbVie

Tarsus Pharmaceuticals

Centricity Vision

Sydnexis

Azura Ophthalmics

iOR Partners

Eyewire News

Ocular Therapeutix’ Axpaxli in Diabetic Retinopathy Evaluated in Phase 1 HELIOS Clinical Trial

Aqueous Humor Proteome Database Established by Medical College of Georgia

Schwind Names Lohith Shetty Head of Global Marketing

Stocks

Cataract

A Need for Scientific Rigor

Dense Cataract in Pseudoexfoliation Syndrome

Rare Case of Retrolenticular Pseudohypopyon

Understanding Posterior Capsule Behavior

The Future of Hyperopic LASIK: Debates and Advances

Management of Advanced Glaucoma

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.12.2024

Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRS

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

04.08.2024

Oculis Announces Positive Results from Phase 3 Trial of Once Daily Treatment for Inflammation and Pain Following Cataract Surgery

Refractive

A Need for Scientific Rigor

The Future of Hyperopic LASIK: Debates and Advances

Essential Preoperative Considerations

Navigating Vitreous Loss in Cataract Surgery

Management of Advanced Glaucoma

The Consumer Journey in Vision Correction

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.11.2024

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgery

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Stay Updated

Follow Eyewire News

Retina

Adopting Remote Monitoring and AI: Lessons From Cardiology

Multimodal Imaging in Uveitis

A Reference Guide for OCT Angiography

Tailoring IVT Dosing With Vitreous Volume

New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT

Practice Makes Progress

04.18.2024

Ocular Therapeutix’ Axpaxli in Diabetic Retinopathy Evaluated in Phase 1 HELIOS Clinical Trial

04.16.2024

Regeneron Backs $500 Million Venture Capital Fund for Biotechnology Innovation

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

04.15.2024

In Japanese Study, Vabysmo Achieves Primary Endpoint in Phase 3 Study for Angioid Streaks

Glaucoma

Establishing a Glaucoma Practice Fresh Out of Fellowship

Seen & Heard

Triple Threat: Combination OMNI and Hyrdus

iTrack Advance With iStent Infinite for Mild POAG

Genetics: Now or Later?

The Glaucoma Tension

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.11.2024

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating Aqueous Outflow Restorative Procedure with OMNI

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Featured Podcasts